115 related articles for article (PubMed ID: 2503341)
1. Mass screening for colorectal cancer.
Khubchandani IT; Karamchandani MC; Kleckner FS; Sheets JA; Stasik JJ; Rosen L; Riether RD
Dis Colon Rectum; 1989 Sep; 32(9):754-8. PubMed ID: 2503341
[TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
Petrelli N; Michalek AM; Freedman A; Baroni M; Mink I; Rodriguez-Bigas M
Surg Oncol; 1994 Feb; 3(1):27-36. PubMed ID: 8186868
[TBL] [Abstract][Full Text] [Related]
4. Hemoccult screening for colorectal cancer.
Chang FC; Jackson TM; Jackson CR
Am J Surg; 1988 Dec; 156(6):457-9. PubMed ID: 3202256
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test.
Cummings KM; Michalek A; Mettlin C; Mittelman A
Cancer; 1984 May; 53(10):2201-5. PubMed ID: 6704908
[TBL] [Abstract][Full Text] [Related]
6. Results of a television-advertised public screening program for colorectal cancer.
McGarrity TJ; Long PA; Peiffer LP; Converse JO; Kreig AF
Arch Intern Med; 1989 Jan; 149(1):140-4. PubMed ID: 2912403
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
Levin B; Hess K; Johnson C
Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
[TBL] [Abstract][Full Text] [Related]
8. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
9. Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test.
Tan WS; Tang CL; Koo WH
Singapore Med J; 2013 Apr; 54(4):220-3. PubMed ID: 23624450
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
[TBL] [Abstract][Full Text] [Related]
12. Cost benefits of hemoccult screening for colorectal carcinoma.
Allison JE; Feldman R
Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287
[TBL] [Abstract][Full Text] [Related]
13. Massive screening for colorectal cancer. A single institution's public commitment.
Petrelli NJ; Palmer M; Michalek A; Herrera L; Mink I; Bersani G; Cummings KM
Arch Surg; 1990 Aug; 125(8):1049-51. PubMed ID: 2116118
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
15. Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity.
Blom J; Törnberg S
J Med Screen; 2017 Sep; 24(3):146-152. PubMed ID: 28142309
[TBL] [Abstract][Full Text] [Related]
16. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
17. Occult blood screening for colorectal carcinoma: a critical review.
Simon JB
Gastroenterology; 1985 Mar; 88(3):820-37. PubMed ID: 3917961
[TBL] [Abstract][Full Text] [Related]
18. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
19. A critical analysis of the largest reported mass fecal occult blood screening program in the United States.
Morris JB; Stellato TA; Guy BB; Gordon NH; Berger NA
Am J Surg; 1991 Jan; 161(1):101-5; discussion 105-6. PubMed ID: 1987842
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
